The unfavorable effect of the A allele of the vitamin D receptor promoter polymorphism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma

References

• Halsall JA, Osborne JE, Potter L, Pringle JH, Hutchinson PE. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma. Br J Cancer 2004; 91:765 - 770
   PubMed Web of Science ®Google Scholar
• Halsall JA, Osborne JE, Pringle JH, Hutchinson PE. Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis. Pharmacogenet Genomics 2005; 15:349 - 355
   PubMed Web of Science ®Google Scholar
• Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167:4974 - 4980
   PubMed Web of Science ®Google Scholar
• Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, Finke JH, et al. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J Exp Med 2002; 196:619 - 628
   PubMed Web of Science ®Google Scholar
• Friedrich M, Krammig S, Henze M, Döcke WD, Sterry W, Asadullah K. Flow cytometric characterization of lesional T cells in psoriasis: Intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype. Arch Dermatol Res 2000; 292:519 - 521
   PubMed Web of Science ®Google Scholar
• Horrocks C, Holder JE, Berth-Jones J, Camp RD. Antigen-independent expansion of T cells from psoriatic skin lesions: Phenotypic characterization and antigen reactivity. Br J Dermatol 1997; 137:331 - 338
   PubMed Web of Science ®Google Scholar
• Schug J, Overton GC. TESS: Transcription Element Search Software on the WWW' 1997;
   Google Scholar
• Sherry ST, Ward MH, Kholodov M, et al. bSNP: The NCBI database of genetic variation. Nucleic Acids Res 2001; 29:308 - 311
   PubMed Web of Science ®Google Scholar
• d'Alésio A, Garabédian M, Sabatier JP, Guaydier-Souquières G, Marcelli C, Lemaçon A, et al. Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls. Hum Mol Genet 2005; 14:3539 - 3548
   PubMed Web of Science ®Google Scholar
• Fang Y, van Meurs JB, d'Alesio A, Jhamai M, Zhao H, Rivadeneira F, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: The rotterdam study. Am J Hum Genet 2005; 77:807 - 823
   PubMed Web of Science ®Google Scholar
• Christakos S, Dhawan P, Peng X, Obukhov AG, Nowycky MC, Benn BS, et al. Vitamin D target proteins: Function and regulation. J Cell Biochem 2003; 88:238 - 244
   PubMed Web of Science ®Google Scholar
• Dhawan P, Peng X, Sutton AL, MacDonald PN, Croniger CM, Trautwein C, et al. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol Cell Biol 2005; 25:472 - 487
   PubMed Web of Science ®Google Scholar
• Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil GS. Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol 2005; 25:706 - 715
   PubMed Web of Science ®Google Scholar
• Cousins DJ, Richards D, Kemeny DM, Romagnani S, Lee TH, Staynov DZ. DNase I footprinting of the human interleukin-5 gene promoter. Immunology 2000; 99:101 - 118
   PubMed Web of Science ®Google Scholar
• Reichrath J, Rech M, Moeini M, Meese E, Tilgen W, Seifert M. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biol Ther 2007; 6:48 - 55
   PubMed Web of Science ®Google Scholar
• Penna G, Adorini L. 1Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405 - 2411
   PubMed Web of Science ®Google Scholar
• Bikle D, Teichert A, Hawker N, Xie Z, Oda Y. Sequential regulation of keratinocyte differentiation by 1,25(OH)2D3, VDR, and its coregulators. J Steroid Biochem Mol Biol 2007; 103:396 - 404
   PubMed Web of Science ®Google Scholar
• Oyama N, Iwatsuki K, Satoh M, Akiba H, Kaneko F. Dermal fibroblasts are one of the therapeutic targets for topical application of 1alpha,25-dihydroxyvitamin D3: The possible involvement of transforming growth factor-beta induction. Br J Dermatol 2000; 143:1140 - 1148
   PubMed Web of Science ®Google Scholar
• Satyamoorthy K, Li G, Vaidya B, Patel D, Herlyn M. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res 2001; 61:7318 - 7324
   PubMed Web of Science ®Google Scholar
• Peng L, Malloy PJ, Feldman D. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol Endocrinol 2004; 18:1109 - 1119
   PubMed Web of Science ®Google Scholar
• Epstein MP, Satten GA. Inference on haplotype effects in case-control studies using unphased genotype data. Am J Hum Genet 2003; 73:1316 - 1329
   PubMed Web of Science ®Google Scholar
• Satten GA, Epstein MP. Comparison of prospective and retrospective methods for haplotype inference in case-control studies. Genet Epidemiol 2004; 27:192 - 201
   PubMed Web of Science ®Google Scholar